Menu

• Ask a Health Expert about HYPERVITAMINOSIS
• Post Your Side Effect related to HYPERVITAMINOSIS
• HYPERVITAMINOSIS and FDA Warnings
• HYPERVITAMINOSIS in Patients Wiki
• Report HYPERVITAMINOSIS in Drug Side Effect Survey

HYPERVITAMINOSIS side effect

What is HYPERVITAMINOSIS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Targretin Side Effects Report #5335982-7
Physician from UNITED STATES reported TARGRETIN problem on Jan 30, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with TARGRETIN. After drug was administered, patient experienced the following problems/side effects: hypervitaminosis, . TARGRETIN dosage: 300 MG QD PO. Patient was hospitalized. Patient recovered.

Duloxetine Side Effects Report #5498013-4
DULOXETINE HYDROCHLORIDE problem was reported by a Physician from ITALY on Oct 15, 2007. Female patient was diagnosed with depression, hypothyroidism, anxiety disorder and was treated with DULOXETINE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, hypervitaminosis, myelodysplastic syndrome, vitamin b12 increased, . DULOXETINE HYDROCHLORIDE dosage: 60 MG, DAILY (1/D). During the same period patient was treated with EUTIROX, TICLOPIDINE HYDROCHLORIDE, LORAZEPAM. Patient recovered.

Targretin Side Effects Report #5335981-5
Physician from UNITED STATES reported TARGRETIN problem on Jan 30, 2006. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia and was treated with TARGRETIN. After drug was administered, patient experienced the following problems/side effects: eye haemorrhage, hypervitaminosis, . TARGRETIN dosage: 150 MG/M^2 DAILY PO. Patient was hospitalized. Patient recovered.

Duloxetine Side Effects Report #5404560-3
DULOXETINE HYDROCHLORIDE problem was reported by a Physician from on July 19, 2007. Female patient, 72 years of age, was diagnosed with depression, hypothyroidism, angiopathy and was treated with DULOXETINE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, haemoglobin decreased, hypervitaminosis, platelet count decreased, red blood cell count decreased, refractory anaemia, . DULOXETINE HYDROCHLORIDE dosage: 60 MG, DAILY (1/D). During the same period patient was treated with EUTIROX, TICLOPIDINE, LORAZEPAM. Patient recovered.